These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 15061433)

  • 1. Clinical effectiveness and cost-effectiveness of Helicobacter pylori testing and treatment in patients receiving long-term ulcer prophylaxis.
    Skog JH; Morreale AP; Plowman BK; Rapier R; Dole S
    Am J Health Syst Pharm; 2004 Mar; 61(6):608-12. PubMed ID: 15061433
    [No Abstract]   [Full Text] [Related]  

  • 2. H pylori in patients with peptic ulcer disease.
    Strickland C
    J Fam Pract; 1998 Feb; 46(2):117. PubMed ID: 9487314
    [No Abstract]   [Full Text] [Related]  

  • 3. Treatment of Helicobacter pylori infection.
    Vakil N
    Am J Ther; 1998 May; 5(3):197-201. PubMed ID: 10099059
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of a Helicobacter pylori treatment strategy on health care expenditures in patients with peptic ulcer disease and dyspepsia.
    Kearney DJ; Liu CF; Crump C; Brousal A
    Am J Gastroenterol; 2003 Sep; 98(9):1952-62. PubMed ID: 14499771
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Eradication therapy in Helicobacter pylori positive peptic ulcer disease: systematic review and economic analysis.
    Ford AC; Delaney BC; Forman D; Moayyedi P
    Am J Gastroenterol; 2004 Sep; 99(9):1833-55. PubMed ID: 15330927
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Helicobacter pylori eradication in ulcer patients. Quality of life improves, costs decline].
    MMW Fortschr Med; 2003 Aug; 145(33-34):55. PubMed ID: 14526577
    [No Abstract]   [Full Text] [Related]  

  • 7. Cost-effectiveness of population screening for Helicobacter pylori in preventing gastric cancer and peptic ulcer disease, using simulation.
    Roderick P; Davies R; Raftery J; Crabbe D; Pearce R; Patel P; Bhandari P
    J Med Screen; 2003; 10(3):148-56. PubMed ID: 14561268
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of peptic ulcer disease: is Helicobacter pylori a consideration?
    Pajares JM; Carballo F; Blanco M
    Hepatogastroenterology; 1992 Feb; 39 Suppl 1():40-4. PubMed ID: 1349551
    [No Abstract]   [Full Text] [Related]  

  • 9. Helicobacter pylori and peptic ulcer disease. Bridging the gap between knowledge and treatment.
    Laine L; Fendrick AM
    Postgrad Med; 1998 Mar; 103(3):231-8, 243. PubMed ID: 9519040
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost-effectiveness of H. pylori eradication.
    Roesch W
    J Physiol Pharmacol; 1996 Mar; 47(1):71-7. PubMed ID: 8777309
    [No Abstract]   [Full Text] [Related]  

  • 11. A simulation to evaluate screening for Helicobacter pylori infection in the prevention of peptic ulcers and gastric cancers.
    Davies R; Crabbe D; Roderick P; Goddard JR; Raftery J; Patel P
    Health Care Manag Sci; 2002 Nov; 5(4):249-58. PubMed ID: 12437272
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The cost-effectiveness of screening for Helicobacter pylori to reduce mortality and morbidity from gastric cancer and peptic ulcer disease: a discrete-event simulation model.
    Roderick P; Davies R; Raftery J; Crabbe D; Pearce R; Bhandari P; Patel P
    Health Technol Assess; 2003; 7(6):1-86. PubMed ID: 12709294
    [No Abstract]   [Full Text] [Related]  

  • 13. Cost-effectiveness of strategies for primary prevention of nonsteroidal anti-inflammatory drug-induced peptic ulcer disease.
    Ko CW; Deyo RA
    J Gen Intern Med; 2000 Jun; 15(6):400-10. PubMed ID: 10886475
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Helicobacter pylori: consensus reached: peptic ulcer is on the way to becoming an historic disease.
    Peura DA; Graham DY
    Am J Gastroenterol; 1994 Aug; 89(8):1137-9. PubMed ID: 8053422
    [No Abstract]   [Full Text] [Related]  

  • 15. H. pylori: scientific basis to patient cure.
    Peura DA
    Rev Gastroenterol Mex; 2006 Aug; 71 Suppl 1():31-3. PubMed ID: 17037765
    [No Abstract]   [Full Text] [Related]  

  • 16. [The drug prophylaxis of peptic ulcer exacerbations].
    Grigor'ev PIa; Iakovenko EP; Agafonova NA; Prianishnikova AS; Soluianova IP; Iakovenko AV; Vasil'ev IV; Agrba VZ; Stepanov AV; Kolodkin AM
    Ter Arkh; 1995; 67(2):26-9. PubMed ID: 7725253
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Peptic ulcer disease in liver cirrhosis: role of Helicobacter pylori infection and therapeutic approach].
    Mitrică D; Constantinescu R; Drug VL; Stanciu C
    Rev Med Chir Soc Med Nat Iasi; 2011; 115(1):27-32. PubMed ID: 21688556
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peptic ulcer disease and current approaches to Helicobacter pylori.
    Hassall E
    J Pediatr; 2001 Apr; 138(4):462-8. PubMed ID: 11295706
    [No Abstract]   [Full Text] [Related]  

  • 19. [Comparison of the effectiveness of tri- and quadricomponent eradication therapy in patients with peptic ulcer].
    Butorov IV; Osoianu IuP; Butorov SI; Maksimov VV
    Klin Med (Mosk); 2005; 83(12):50-3. PubMed ID: 16502725
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Screening to Identify and Eradicate Helicobacter pylori Infection in Teenagers in Japan.
    Akamatsu T; Okamura T; Iwaya Y; Suga T
    Gastroenterol Clin North Am; 2015 Sep; 44(3):667-76. PubMed ID: 26314676
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.